Federico Lucantoni

Metabolic Targeting of Breast Cancer Cells With the 2-Deoxy-D-Glucose and the Mitochondrial Bioenergetics Inhibitor MDIVI-1

Federico Lucantoni, Jochen H.M. Prehn · Frontiers in Cell and Developmental Biology · 2018 · 52 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Systems modeling accurately predicts responses to genotoxic agents and their synergism with BCL-2 inhibitors in triple negative breast cancer cells

Federico Lucantoni, Andreas U. Lindner, Norma O’Donovan et al. · Cell Death and Disease · 2018 · 48 citations · Full text

Life Sciences, Cell Biology, Oncology +17

BCL2 and BCL(X)L selective inhibitors decrease mitochondrial ATP production in breast cancer cells and are synthetically lethal when combined with 2-deoxy-D-glucose

Federico Lucantoni, Irene Llorente‐Folch, Jochen H.M. Prehn · Oncotarget · 2018 · 48 citations · Full text

Life Sciences, Cell Biology, Oncology +17

BCL(X)L and BCL2 increase the metabolic fitness of breast cancer cells: a single-cell imaging study

Federico Lucantoni, Manuela Salvucci, Andreas U. Lindner et al. · Cell Death and Differentiation · 2020 · 31 citations · Full text

Life Sciences, Cell Biology, Oncology +15

Low cleaved caspase-7 levels indicate unfavourable outcome across all breast cancers

Andreas U. Lindner, Federico Lucantoni, Damir Varešlija et al. · Journal of Molecular Medicine · 2018 · 21 citations · Full text

Medicine, Oncology, Pathology +12